Dynamin Inhibition Reveals Viral Entry Pathways in Grass Carp Reovirus

Study Background and Research Question

Grass carp (Ctenopharyngodon idella) is a critical aquaculture species in Asia, but outbreaks of hemorrhagic disease caused by grass carp reovirus (GCRV) have led to significant economic losses. Of the three known genotypes of GCRV, genotype III (represented by GCRV104) is particularly concerning due to a lack of available vaccines and limited understanding of its cellular entry mechanism. The research question addressed by Wang et al. (2018) was to elucidate the molecular pathway by which GCRV104 enters grass carp kidney (CIK) cells, with a focus on the role of endocytic pathways and the involvement of specific cellular factors such as dynamin GTPase (Wang et al., 2018).

Key Innovation from the Reference Study

The primary innovation of this study lies in its comprehensive pharmacological inhibitor analysis, which directly interrogates the cellular entry mechanism of GCRV104. By systematically applying a panel of inhibitors targeting clathrin-mediated endocytosis, caveolar pathways, macropinocytosis, and intracellular trafficking components, the researchers were able to pinpoint the critical dependence of GCRV104 on clathrin-mediated, dynamin-dependent endocytosis. The use of a well-characterized dynamin GTPase inhibitor in live cell models provided robust evidence that dynamin activity is indispensable for viral uptake, setting a new methodological standard for aquatic virology research.

Methods and Experimental Design Insights

Wang et al. employed a multi-pronged experimental approach to dissect the entry pathway of GCRV104. Their workflow included:

• Pharmacological inhibition: A range of small molecule inhibitors were used to target specific endocytic pathways. Notably, Dynasore, a noncompetitive dynamin GTPase inhibitor, was applied to block dynamin-mediated events.
• Cellular infection assays: The grass carp kidney (CIK) cell line was infected with either GCRV104 (genotype III) or GCRV-JX01 (genotype I), and cytopathic effects were monitored.
• Quantitative viral replication analysis: Real-time quantitative PCR (qPCR) was used to measure viral RNA levels post-infection, providing quantitative assessment of entry and replication efficiency.
• Transmission electron microscopy (TEM): Ultrastructural analysis confirmed viral internalization and trafficking within host cells.

This systematic use of pharmacological inhibitors—paired with direct imaging and molecular quantification—enabled a nuanced dissection of viral entry mechanisms.

Core Findings and Why They Matter

The study found that GCRV104 entry into CIK cells is critically dependent on both clathrin-mediated endocytosis and dynamin GTPase activity. Key findings include:

• Both GCRV104 and GCRV-JX01 can infect CIK cells, but GCRV104 replicates significantly more slowly, with titers 1,000-fold lower at 24 hours post-infection.
• Pharmacological inhibition using agents such as ammonium chloride (endosomal acidification blocker), Dynasore (dynamin inhibitor), chlorpromazine (clathrin pathway inhibitor), and Pitstop2 (clathrin inhibitor) significantly reduced viral entry and replication as measured by qPCR and cytopathic effect.
• In contrast, inhibitors of caveolar endocytosis (nystatin, methyl-β-cyclodextrin), macropinocytosis (IPA-3, amiloride), and cytoskeletal components (nocodazole, latrunculin B) did not significantly impair viral uptake.
• Dynasore treatment was particularly notable for its potent reduction of both GCRV104 and GCRV-JX01 infection rates, supporting the indispensable role of dynamin in viral internalization (Wang et al., 2018).

These results provide the first direct evidence that genotype III GCRV relies on clathrin-mediated, dynamin-dependent endocytosis for cellular entry. The implications are significant for endocytosis research, viral pathogenesis studies, and the development of targeted antiviral strategies in aquaculture.

Comparison with Existing Internal Articles

Several internal resources expand on the methodological and practical aspects of dynamin inhibition in endocytosis research. For instance, the article "Clathrin-Mediated Entry of Grass Carp Reovirus: Dynasore Insights" interprets the Wang et al. findings within the broader context of aquatic virology, emphasizing the specificity of dynamin's role as revealed by Dynasore. Another resource, "Dynasore: Noncompetitive Dynamin GTPase Inhibitor for Endocytosis Research", provides an overview of Dynasore's selectivity and its established use in dissecting signal transduction and viral entry mechanisms. These articles collectively support the view that pharmacological inhibition of dynamin is both a diagnostic and mechanistic tool in endocytosis research. Moreover, evidence-based guidance for experimental design—such as those outlined in "Dynasore (SKU A1605): Data-Driven Solutions for Endocytosis"—can help laboratories ensure reproducibility and interpretability when targeting dynamin-dependent pathways.

Limitations and Transferability

While the inhibitor-based approach provides strong evidence for the involvement of clathrin and dynamin in GCRV104 entry, several limitations should be considered:

• Pharmacological inhibitors, including Dynasore, can have off-target effects or varying efficacy depending on cell type and experimental conditions.
• The study focused exclusively on CIK cells, and thus the generalizability to other cell types—or to in vivo systems—remains to be established.
• Temporal resolution of inhibitor application versus viral entry was not exhaustively characterized, which may impact interpretation of dynamin’s role at different infection stages.
• Transferability to other aquatic or terrestrial viral systems requires further validation.

Nevertheless, the robust decrease in viral entry upon dynamin inhibition provides a strong foundation for future studies and potential antiviral intervention strategies.

Protocol Parameters

• Dynasore treatment: Pre-treat CIK cells with Dynasore at concentrations effective for dynamin inhibition (see product information)—the reference study utilized inhibitor concentrations in the low micromolar range, with significant effects observed at 15–80 µM.
• Viral infection protocol: Infect cells immediately following inhibitor treatment and monitor viral uptake via qPCR and cytopathic effect at defined intervals (e.g., 6–24 hours post-infection).
• Controls: Include untreated and vehicle-treated controls, as well as parallel treatments with other pathway-specific inhibitors for mechanistic comparison.

Why this cross-domain matters, maturity, and limitations

This research bridges aquatic virology and fundamental cell biology by demonstrating that viral pathogens can exploit highly conserved mammalian endocytic machinery—even in fish cell systems. The maturity of this approach is supported by extensive pharmacological validation and the use of established molecular inhibitors; however, further studies are needed to confirm these findings in vivo and across diverse host contexts. Limitations include potential off-target effects of inhibitors and the need for orthogonal validation, such as genetic knockdown or rescue experiments.

Outlook

By establishing dynamin-dependent, clathrin-mediated endocytosis as the primary entry route for GCRV104, Wang et al. (2018) open new avenues for targeted antiviral research in aquaculture. These insights may inform both the rational design of pharmacological interventions and the refinement of in vitro infection models for broader endocytosis research and signal transduction pathway studies.

Research Support Resources

To facilitate similar investigations of endocytic pathways, researchers can utilize Dynasore (SKU A1605), a validated dynamin GTPase inhibitor with an IC50 of approximately 15 µM. Dynasore is widely used in endocytosis, synaptic vesicle endocytosis inhibition, and signal transduction pathway study applications, as detailed by APExBIO. It offers reversible, dose-dependent inhibition of dynamin family GTPases, supporting robust and interpretable dissection of cellular entry mechanisms in both viral and non-viral systems.